Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
                
Learn More
Learn More
                                    Tie-2 Antibody (MM0018-21G7), PE, Novus Biologicals™
                                    
                                    
                                    
                                    
                                
                            
                            
                            
                            
Mouse Monoclonal Antibody
Supplier: Novus Biologicals NB11060986PE
Description
Tie-2 Monoclonal antibody specifically detects Tie-2 in Human samples. It is validated for Western Blot, ELISA, Immunohistochemistry, Immunohistochemistry (Paraffin)Specifications
| Tie-2 | |
| Monoclonal | |
| PE | |
| PBS | |
| Mouse | |
| Protein G purified | |
| RUO | |
| Primary | |
| Human | |
| Purified | 
| Western Blot, ELISA, Immunohistochemistry, Immunohistochemistry (Paraffin) | |
| MM0018-21G7 | |
| Western Blot, ELISA, Immunohistochemistry, Immunohistochemistry-Paraffin | |
| angiopoietin-1 receptor, CD202B, CD202b antigen, EC 2.7.10, EC 2.7.10.1, hTIE2, p140 TEK, soluble TIE2 variant 1, soluble TIE2 variant 2, TEK tyrosine kinase, endothelial, TIE-2, TIE2CD202b, Tunica interna endothelial cell kinase, Tyrosine-protein kinase receptor TEK, Tyrosine-protein kinase receptor TIE-2, venous malformations, multiple cutaneous and mucosal, VMCM, VMCM1 | |
| This antibody was produced from a hybridoma (mouse myeloma fused with spleen cells from a mouse immunized with purified human extracellular domain of Tie2 fragment). | |
| 0.1 mL | |
| Angiogenesis, Cancer, Phospho Specific, Protein Kinase | |
| 7010 | |
| Store at 4C in the dark. | |
| IgG1 | 
                    Product Content Correction
                
                Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
			
            Spot an opportunity for improvement?Share a Content Correction